HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Brief report Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome
نویسندگان
چکیده
1Université Paris Descartes, Assistance Publique–Hopitaux de Paris (AP-HP), Hôpital Necker, Department of Nephrology, and Inserm U845, Paris, France; 2Department of Gynecology and Obstetrics, Hôpital Saint-Vincent de Paul, Paris, France; 3AP-HP, Department of Immunology, Hopital Européen Georges Pompidou, Paris, France; 4Department of Gynecology and Obstetrics, Hôpital Necker, Paris, France, 5Department of Nephrology, Centre Hospitalier Universitaire (CHU), Nantes, France; 6Department of Nephrology, Université Catholique de Louvain, Brussels, Belgium; 7Department of Nephrology, CHU Bicêtre, Le Kremlin Bicêtre, France; and 8Centre de Recherche des Cordeliers, Inserm Unité Mixte de Recherche en Santé (UMRS) 872, Paris, France
منابع مشابه
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy with manifestations of hemolytic anemia, thrombocytopenia, and renal impairment. Genetic studies have shown that mutations in complement regulatory proteins predispose to non–Shiga toxin–associated HUS (non-Stx–HUS). We undertook genetic analysis on membrane cofactor protein (MCP), complement factor H (CFH), and factor I (IF) in 15...
متن کاملHEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet -granule biogenesis
Bleeding problems are associated with defects in platelet -granules, yet little is known about how these granules are formed and released. Mutations affecting VPS33B, a novel Sec1/Munc18 protein, have recently been linked to arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome. We have characterized platelets from patients with ARC syndrome and observed reduced aggregation with ara...
متن کاملEculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.
Atypical hemolytic uremic syndrome (aHUS) is a genetic, life-threatening disease characterized by uncontrolled complement activation, systemic thrombotic microangiopathy (TMA), and vital organ damage. We evaluated the effect of terminal complement blockade with the anti-C5 monoclonal antibody eculizumab on biomarkers of cellular processes involved in TMA in patients with aHUS longitudinally, du...
متن کاملvon Willebrand factor: a marker of endothelial damage?
Von Willebrand factor (vWF), a large glycoprotein encoded by a gene on chromosome 12, is synthesized by vascular endothelial cells and circulates in human plasma at concentrations of 10 mg/mL.* In plasma, vWF forms a noncovalent complex with coagulation factor VIII, the protein encoded by a gene on the X chromosome that is deficient or defective in hemophilia A. This molecular complex is essent...
متن کاملFactor V and thrombotic disease: description of a janus-faced protein.
The generation of thrombin by the prothrombinase complex constitutes an essential step in hemostasis, with thrombin being crucial for the amplification of blood coagulation, fibrin formation, and platelet activation. In the prothrombinase complex, the activated form of coagulation factor V (FVa) is an essential cofactor to the enzyme-activated factor X (FXa), FXa being virtually ineffective in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008